Provided by Tiger Trade Technology Pte. Ltd.

SINOPHARM

14.620
-0.240-1.62%
Volume:1.91M
Turnover:28.13M
Market Cap:45.63B
PE:6.38
High:14.980
Open:14.860
Low:14.580
Close:14.860
52wk High:21.258
52wk Low:14.580
Shares:3.12B
HK Float Shares:1.34B
Volume Ratio:1.45
T/O Rate:0.14%
Dividend:0.79
Dividend Rate:5.40%
EPS(LYR):2.290
ROE:8.04%
ROA:2.55%
PB:0.46
PE(LYR):6.38
PS:0.07

Loading ...

Sinopharm unveils AGM agenda: seeks mandates for 30% guarantee cap, 20% share issuance, 10% H-share buy-back and extension of debt registration

Bulletin Express
·
May 28

Sinopharm Sets 18 June 2026 AGM; Tables RMB0.69 Final Dividend, 20% Issue Mandate and 10% H-Share Buyback

Bulletin Express
·
May 28

Sinopharm Group announces annual shareholder meeting

Reuters
·
May 28

Sinopharm Group Stock Falls 1.7% in Hong Kong

Dow Jones
·
May 27

Sinopharm Group Stock Sheds 1.2% in Hong Kong

Dow Jones
·
May 21

Sinopharm Group Stock Falls 2.1% in Hong Kong

Dow Jones
·
May 18

FMR LLC Reduces Stake in SINOPHARM, Selling Shares at HK$18.4051 Each

Stock News
·
May 15

China Traditional Chinese Medicine names Chen Kun as non-executive director

Reuters
·
May 15

China TCM wins China approval for Shaoyao Gancao Tang granules

Reuters
·
May 11

Sinopharm Group Stock Sheds 1.6% in Hong Kong

Dow Jones
·
May 08

Sinopharm Group Stock Advances 1.4% in Hong Kong

Dow Jones
·
May 04

Sinopharm Accord Q1 net profit falls 12.36% to RMB 287.46 million

Reuters
·
Apr 29

Sinopharm Group Stock Rallies 1.9% in Hong Kong

Dow Jones
·
Apr 29

Sinopharm Group Stock Falls 3.8% in Hong Kong

Dow Jones
·
Apr 27

Stock Track | SINOPHARM Plummets 5.05% Intraday on Weak Q1 2026 Results Showing Revenue and Profit Decline

Stock Track
·
Apr 27

BUZZ-Sinopharm Group touches 6-month low as quarterly profit slips

Reuters
·
Apr 27

Sinopharm Group Records Drop in Q1 2026 Profit

MT Newswires Live
·
Apr 27

BRIEF-Sinopharm Group Posts Qtrly Total Operating Revenue RMB 140.77 Billion

Reuters
·
Apr 27

SINOPHARM Reports Q1 Net Profit of 1.41 Billion Yuan, Down 2.95% Year-on-Year

Stock News
·
Apr 27

Sinopharm Q1-2026: Revenue Slips 0.6%, Attributable Profit Down 3.0% amid Higher Working-Capital Needs

Bulletin Express
·
Apr 27